GENEVA, July 2 -- CURSUS BIO INC. filed a patent application (KR2024/097000) for “NUCLEIC ACID CONSTRUCT FOR INHIBITING FABP4 AND COMPOSITION FOR TREATING OBESITY OR OBESITY-DERIVED METABOLIC DISEASES COMPRISING SAME”. With publication no. WO/2026/134402, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....